Pathology Clinical Trial
Official title:
Clinical Validation for Non-Inferiority of Primary Diagnosis by WSI Hamamatsu NanoZoomer S360MD Digital Slide Scanner System Compared to Conventional Determination by Light Microscope
NCT number | NCT03991468 |
Other study ID # | HCT-P001 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | March 15, 2019 |
Est. completion date | July 31, 2021 |
Verified date | November 2022 |
Source | Hamamatsu Photonics K.K. |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The primary objective of this study is to evaluate the safety and accuracy of the Hamamatsu WSI compared to those of the reference method (conventional light microscope (Glass)) under clinical use conditions as an aid for pathologists to view, review and diagnose digital images of surgical pathology slides. The primary endpoint is the indicator of major discordance in primary diagnosis between ground truth case diagnosis and case diagnosis by each modality, WSI and Glass, separately.
Status | Completed |
Enrollment | 2000 |
Est. completion date | July 31, 2021 |
Est. primary completion date | July 31, 2021 |
Accepts healthy volunteers | No |
Gender | All |
Age group | N/A and older |
Eligibility | Inclusion Criteria: - Cases originating from and that were diagnosed at that local site - Cases are available in the site's archive - Cases are at least 1 year old since accessioning - Cases are selected because their primary diagnosis is consistent with the assigned target categories - Cases have a set of slides representative of the primary diagnosis for which it has been selected Slide selection for a given case must meet the following criteria: - Slide is obtained by surgical pathology and prepared from FFPE human tissue - Slides must be stained with H&E and accompanying special stains (histochemical and/or immunohistochemical) - All special stains slides (histochemical and/or immunohistochemical) where the slide and stain is used for diagnosis, not prognosis. - A chosen slide must demonstrate and be representative of the primary diagnosis; 1 slide selection may suffice for biopsy cases, - For resection cases, a minimum of 5 slides must be selected, which represent the primary diagnosis. If represented with less than 5 slides, additional slides (primary, secondary, or benign slides) from same case may be used to fulfill minimum number - Slide is intact, has correct size/thickness, good edges, undamaged coverslip, without pen markings that can't be removed, no air bubbles, tidy labels, and fulfills the quality checks per the general clinical practice Exclusion Criteria: - Case does not have relevant slides or if case information necessary for the study is missing - Case is still active (less than 1 year old) at the local site - Cases for which the control slides for immunohistochemistry and special stains are not available - Two cases from same individual - Gross-only cases that have no slides - Cases that are frozen section, cytology or hematology or immunofluorescence specimens only - Case where the only available set of slides have evidence only of secondary or no diagnoses and not the primary diagnosis for which the case is being screened. Slides for a given case will be excluded if they meet the following criterion: • Glass slide that is broken, has abnormal size/thickness, beveled edges, poor coverslip (cracks, waviness, scratches), is sticky, has many pen markings or dirt that cannot be removed, contains air bubbles and overhanging labels that can't be corrected, and if stain is severely faded. |
Country | Name | City | State |
---|---|---|---|
United States | TriCore Reference Laboratories | Albuquerque | New Mexico |
United States | The Cleveland Clinic Foundation | Cleveland | Ohio |
United States | The Ohio State University | Columbus | Ohio |
United States | Washington University | Saint Louis | Missouri |
Lead Sponsor | Collaborator |
---|---|
Hamamatsu Photonics K.K. |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Major Discordance Rate | Indpendent reads by four Reading Pathologists (RPs) of both imaging modalitites (8 reads/case) were compared to the original diagnosis ("ground truth" or GT) by an independent adjudication process. This resulted in one of four adjudication outcomes for each read: "Match" (read = GT), "Minor" (minor discordance between read & GT), "Major" (major discordance between read & GT), or "Deferred" (read deferred by RP and excluded from the primary endpoint analysis). The outcome measure was the rate at which major discordances occurred for each modality. | 1 day |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06035250 -
AI Prediction of Gastric Cancer Response to Neoadjuvant Chemotherapy
|
||
Not yet recruiting |
NCT04788927 -
Development of a Predictive Model for the Risk of Metastatic Disease in PPGLs, a Retrospective Cohort Study
|
||
Not yet recruiting |
NCT05565677 -
Prognostic Value of Lung Cancer MicroAnatomy in 3D
|
||
Recruiting |
NCT05191433 -
Effects of Mechanical Ventilation on the Diaphragm in COVID-19 Intensive Care Patients. A Post-mortem Pathology Study
|
||
Recruiting |
NCT04809025 -
Comparation of Endoscopic Biopsy and Postoperative Specimen for the Molecular Diagnosis of Gastric Cancer
|
||
Recruiting |
NCT05218460 -
Evaluation of Methodological and Technical DEvelopmeNts to Improve the Quality and Comfort of Magnetic Resonance Imaging Exam on Voluntary Subjects
|
N/A | |
Recruiting |
NCT02436122 -
Impact of Preoperative HbA1c Levels on Pathologic Features and Oncological Outcomes in the Patients With Prostate Cancer
|
N/A | |
Not yet recruiting |
NCT01569555 -
Significant Pathology Associated With Crossed Leg Sign
|
N/A | |
Not yet recruiting |
NCT01569542 -
Crossed Leg Sign and it's Correlation With Significant Pathology
|
N/A | |
Active, not recruiting |
NCT01993199 -
Deep Biopsy Via Endoscopic Submucosal Dissection in Upper GI Subepithelial Tumors
|
N/A | |
Recruiting |
NCT04879056 -
Instrument Precision Study for Validation of PIPS 5.1
|
||
Completed |
NCT03986268 -
Vitamin D Can Increase Pathological Response of the Breast Cancer Patients Treated With Neoadjuvant Therapy
|
N/A | |
Completed |
NCT05983003 -
Research on Identifying and Treatment Prognosis of Chronic Rhinosinusitis Based on Image and Sequencing Data
|
||
Completed |
NCT04356768 -
Histological Analysis of Sacrococcygeal Pilonidal Sinus Specimens
|
||
Recruiting |
NCT03230994 -
Cooperative Adenomyosis Network
|
||
Completed |
NCT01628250 -
Laparoscopic Complete Mesocolic Excision on Colon Cancer
|
N/A | |
Completed |
NCT03992768 -
Feature Detection Study for Validation of Hamamatsu NanoZoomer S360MD Digital Slide Scanner System
|
N/A | |
Not yet recruiting |
NCT04956601 -
Adjuvant Radiotherapy in Patients With Early Endometrial Cancer
|
N/A | |
Completed |
NCT02971072 -
Neurophysiology of Weakness and Exercise in Rotator Cuff Tendinopathy
|
N/A | |
Completed |
NCT03872362 -
Radiomics Multifactorial Biomarker for Pulmonary Nodules
|